2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗

2020-01-07 国外内分泌相关专家小组(统称) Exp Clin Endocrinol Diabetes. 2020 Jan 7.

甲状腺结节和囊肿比较常见,手术治疗是有症状甲状腺结节,疑似恶性肿瘤结节和甲状腺癌的标准治疗方法,放射性碘治疗主要用于具有自主功能的结节。本文主要针对甲状腺良性结节非手术以及非放射性碘消融治疗提供指导建议。

中文标题:

2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗

英文标题:

Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation.

发布日期:

2020-01-07

简要介绍:

甲状腺结节和囊肿比较常见,手术治疗是有症状甲状腺结节,疑似恶性肿瘤结节和甲状腺癌的标准治疗方法,放射性碘治疗主要用于具有自主功能的结节。本文主要针对甲状腺良性结节非手术以及非放射性碘消融治疗提供指导建议。

 

拓展指南:甲状腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗)] GetToolGuiderByIdResponse(projectId=1, id=fa1011c0018519d4, title=2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗, enTitle=Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation., guiderFrom=Exp Clin Endocrinol Diabetes. 2020 Jan 7., authorId=null, author=, summary=甲状腺结节和囊肿比较常见,手术治疗是有症状甲状腺结节,疑似恶性肿瘤结节和甲状腺癌的标准治疗方法,放射性碘治疗主要用于具有自主功能的结节。本文主要针对甲状腺良性结节非手术以及非放射性碘消融治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=949, associationName=国外内分泌相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Tue Jan 07 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>甲状腺结节和囊肿比较常见,手术治疗是有症状甲状腺结节,疑似恶性肿瘤结节和甲状腺癌的标准治疗方法,放射性碘治疗主要用于具有自主功能的结节。本文主要针对甲状腺良性结节非手术以及非放射性碘消融治疗提供指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>甲状腺</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=73a911c0018a4299" title="甲状腺功能减退症基层诊疗指南(实践版·2019)" target=_blank>甲状腺功能减退症基层诊疗指南(实践版·2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1abc31c0018a2112" title="2019 专家共识:乐伐替尼治疗甲状腺癌期间不良事件的管理" target=_blank>2019 专家共识:乐伐替尼治疗甲状腺癌期间不良事件的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=e5a141c0018330c5" title="2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查" target=_blank>2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=8f5dc1c001823621" title="分化型甲状腺癌术后 131 I治疗前评估专家共识" target=_blank>分化型甲状腺癌术后 131 I治疗前评估专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3514d1c0018103a0" title="甲状腺微小乳头状癌热消融诊疗指征专家共识" target=_blank>甲状腺微小乳头状癌热消融诊疗指征专家共识</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA" target=_blank>有关甲状腺更多指南</a></ul>, tagList=[TagDto(tagId=37329, tagName=甲状腺良性结节), TagDto(tagId=14749, tagName=非手术治疗), TagDto(tagId=98998, tagName=非放射性碘消融治疗)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5158, appHits=312, showAppHits=6, pcHits=2289, showPcHits=3738, likes=55, shares=8, comments=5, approvalStatus=1, publishedTime=Wed Jan 22 20:04:55 CST 2020, publishedTimeString=2020-01-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Jan 22 20:04:55 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 12:01:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗)])
2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=971173, encodeId=77119e1173c1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512b5474231, createdName=ms1000001707411054, createdTime=Sat Jun 05 20:40:16 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914428, encodeId=b90b91442856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Jan 07 16:01:44 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896437, encodeId=aa8b89643ebb, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/22/50931b0c0452fd1045efff499e4131ec.jpg, createdBy=e7922319867, createdName=醫喆芢鑫, createdTime=Mon Nov 02 23:51:25 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
    2021-06-05 ms1000001707411054

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=971173, encodeId=77119e1173c1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512b5474231, createdName=ms1000001707411054, createdTime=Sat Jun 05 20:40:16 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914428, encodeId=b90b91442856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Jan 07 16:01:44 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896437, encodeId=aa8b89643ebb, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/22/50931b0c0452fd1045efff499e4131ec.jpg, createdBy=e7922319867, createdName=醫喆芢鑫, createdTime=Mon Nov 02 23:51:25 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
    2021-01-07 Mr.d

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=971173, encodeId=77119e1173c1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512b5474231, createdName=ms1000001707411054, createdTime=Sat Jun 05 20:40:16 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914428, encodeId=b90b91442856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200820/a50c79dfbf8443c28d9507e5ed481752/4f3848e242344bd8a14c3db699d30a7b.jpg, createdBy=da5f5248805, createdName=Mr.d, createdTime=Thu Jan 07 16:01:44 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896437, encodeId=aa8b89643ebb, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/22/50931b0c0452fd1045efff499e4131ec.jpg, createdBy=e7922319867, createdName=醫喆芢鑫, createdTime=Mon Nov 02 23:51:25 CST 2020, time=2020-11-02, status=1, ipAttribution=)]
    2020-11-02 醫喆芢鑫

    0